Foreign-Trade Zone (FTZ) 61-San Juan, Puerto Rico, Notification of Proposed Production Activity, Janssen Ortho LLC (Pharmaceutical Products Production), Gurabo, Puerto Rico, 30270 [2013-12214]

Download as PDF 30270 Federal Register / Vol. 78, No. 99 / Wednesday, May 22, 2013 / Notices public comment (78 FR 7395, 02/01/ 2013). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board’s regulations, including Section 400.14. Dated: May 17, 2013. Andrew McGilvray, Executive Secretary. [FR Doc. 2013–12222 Filed 5–21–13; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–46–2013] TKELLEY on DSK3SPTVN1PROD with NOTICES Foreign-Trade Zone (FTZ) 61—San Juan, Puerto Rico, Notification of Proposed Production Activity, Janssen Ortho LLC (Pharmaceutical Products Production), Gurabo, Puerto Rico The Puerto Rico Trade and Export Company, grantee of FTZ 61, submitted a notification of proposed production activity to the FTZ Board on behalf of Janssen Ortho LLC (Janssen), located in Gurabo, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on April 29, 2013. A separate application for subzone status at the Janssen facility was submitted and will be processed under Section 400.31 of the FTZ Board’s regulations. The facility is used for the production of various prescription and over-the-counter pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status materials and components and specific finished products listed in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Janssen from customs duty payments on the foreign status components used in export production. On its domestic sales, Janssen would be able to choose the duty rates during customs entry procedures that apply to various prescription and over-thecounter pharmaceutical products, including: Anti-cancer; anti-diabetic and immunosuppressive medicaments; analgesics; antipyretic and antiinflammatory agents; and, cough and cold preparations (duty free) for the foreign status inputs noted below. Customs duties also could possibly be deferred or reduced on foreign status production equipment. VerDate Mar<15>2010 16:59 May 21, 2013 Jkt 229001 The components and materials sourced from abroad include: Splenda sucralose; cobicistate silicon dioxide; metformin; canagliflozin; and darunavir ethanolate API (duty rates range from 86.2 cents/kg to 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is July 1, 2013. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. FOR FURTHER INFORMATION CONTACT: Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: May 16, 2013. Andrew McGilvray, Executive Secretary. [FR Doc. 2013–12214 Filed 5–21–13; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board proposed subzone would be subject to the existing activation limit of FTZ 247. In accordance with the Board’s regulations, Elizabeth Whiteman of the FTZ Staff is designated examiner to review the application and make recommendations to the Executive Secretary. Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is July 1, 2013. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to July 16, 2013. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Elizabeth Whiteman at Elizabeth.Whiteman@trade.gov or (202) 482–0473. Dated: May 16, 2013. Andrew McGilvray, Executive Secretary. [FR Doc. 2013–12218 Filed 5–21–13; 8:45 am] [S–69–2013] BILLING CODE 3510–DS–P Foreign-Trade Zone 247—Erie, Pennsylvania; Application for Subzone; GE Transportation, Lawrence Park Township, Pennsylvania An application has been submitted to the Foreign-Trade Zones Board (the Board) by the Erie-Western Pennsylvania Port Authority, grantee of FTZ 247, requesting special-purpose subzone status for the facility of GE Transportation, located in Lawrence Park Township, Pennsylvania. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a– 81u), and the regulations of the Board (15 CFR part 400). It was formally docketed on May 16, 2013. The proposed subzone (350 acres) is located at 2901 East Lake Road, Lawrence Park Township, Erie County, Pennsylvania. No production activity has been requested at this time, but the company has indicated that a notification of proposed production activity will be submitted. Any such notifications will be published separately for public comment. The PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [S–70–2013] Foreign-Trade Zone 247—Erie, Pennsylvania, Application for Subzone, GE Transportation, Grove City, Pennsylvania An application has been submitted to the Foreign-Trade Zones Board (the Board) by the Erie-Western Pennsylvania Port Authority, grantee of FTZ 247, requesting special-purpose subzone status for the facility of GE Transportation, located in Grove City, Pennsylvania. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board (15 CFR part 400). It was formally docketed on May 16, 2013. The proposed subzone (49 acres) is located at 1503 West Main Street Ext., Grove City, Mercer County, Pennsylvania. No production activity has been requested at this time, but the E:\FR\FM\22MYN1.SGM 22MYN1

Agencies

[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Page 30270]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12214]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-46-2013]


Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico, Notification 
of Proposed Production Activity, Janssen Ortho LLC (Pharmaceutical 
Products Production), Gurabo, Puerto Rico

    The Puerto Rico Trade and Export Company, grantee of FTZ 61, 
submitted a notification of proposed production activity to the FTZ 
Board on behalf of Janssen Ortho LLC (Janssen), located in Gurabo, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on April 29, 
2013.
    A separate application for subzone status at the Janssen facility 
was submitted and will be processed under Section 400.31 of the FTZ 
Board's regulations. The facility is used for the production of various 
prescription and over-the-counter pharmaceutical products. Pursuant to 
15 CFR 400.14(b), FTZ activity would be limited to the specific 
foreign-status materials and components and specific finished products 
listed in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Janssen from customs 
duty payments on the foreign status components used in export 
production. On its domestic sales, Janssen would be able to choose the 
duty rates during customs entry procedures that apply to various 
prescription and over-the-counter pharmaceutical products, including: 
Anti-cancer; anti-diabetic and immunosuppressive medicaments; 
analgesics; antipyretic and anti-inflammatory agents; and, cough and 
cold preparations (duty free) for the foreign status inputs noted 
below. Customs duties also could possibly be deferred or reduced on 
foreign status production equipment.
    The components and materials sourced from abroad include: Splenda 
sucralose; cobicistate silicon dioxide; metformin; canagliflozin; and 
darunavir ethanolate API (duty rates range from 86.2 cents/kg to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is July 1, 2013.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.

FOR FURTHER INFORMATION CONTACT: Diane Finver at Diane.Finver@trade.gov 
or (202) 482-1367.

    Dated: May 16, 2013.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2013-12214 Filed 5-21-13; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.